Skip to main content
Clinical Trials/CTRI/2012/04/002566
CTRI/2012/04/002566
Completed
Phase 4

A study to compare the symptomatic response in Indian menopausal women with different Estrogen preparations for treatment of vasomotor symptoms/vaginal atrophy

Walter Bushnell Pvt Ltd0 sites200 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Walter Bushnell Pvt Ltd
Enrollment
200
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Pms

Investigators

Sponsor
Walter Bushnell Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.Menopausal women upto 70 years of age
  • 2\.Symptomatic women with natural menopause
  • 3\.Hysterectomised women with one or both ovaries preserved, considered only if serum FSH \>40 IU/L and serum estradiol \< 20 IU/L
  • 4\.Women with bilateral oophrectomy
  • 5\.Women with menopause due to premature ovarian failure
  • 6\.Amenorrhoea for more than 1 year
  • 7\.Currently experiencing vasomotor symptoms i.e hot flushes, night sweats, insomnia, sleep disturbances
  • 8\.Currently experiencing dyspareunia, urinary symptoms such as frequency, urgency, dysuria, burning micturition, incontinence etc.

Exclusion Criteria

  • 1\.Tobacco or alcohol abuser.
  • 2\.History of malignant diseases.
  • 3\.Abnormal mammogram within two years of study entry
  • 4\.History of hormone dependent tumors
  • 5\.Women with chronic diseases, such as uncontrolled hypertension; diabetes; liver, kidney and thyroid dysfunction
  • 6\.Women on Long\-term therapy such as Antiepileptic drugs or Diuretics
  • 7\.Prior intake of hormonal medications within the 3 months
  • 8\.Women with history of thrombophlebitis, estrogen\-related thrombosis or thromboembolism, Cerebrovascular accident, with known or suspected estrogen\-dependent tumor, undiagnosed vaginal bleeding, Migraine, Uterine disorders, Breast disorders, Gallbladder disease, Areterial thrombosis and Hypercholesterolemia
  • 9\.Obese women: BMI36
  • 10\.Known hypersensitivity to drugs used in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials